rsv enflonsia - Search News

News

FDA, RSV and Enflonsia

FDA Approves Merck’s Enflonsia to prevent RSV in infants

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.

Clinical Trials Arena · 1d

MSD’s Enflonsia receives FDA approval for RSV prophylaxis

Infectious Disease Advisor · 19h

Enflonsia Approved for RSV Disease Prevention in Infants

1don MSN

Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

18h

New Antibody Shot Could Help Protect Babies From RSV

THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial ...

Fierce Pharma3d

Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's Beyfortus

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

CIDRAP3d

RSV, flu linked to 6% and 3% of kids' antibiotic prescriptions

Estimates varied from 2008 through 2018, with RSV-associated antibiotic prescribing exceeding 10% in peak RSV years and ...

16h

New RSV vaccine keeps 400-plus Qld babies out of hospital

A vaccine targeting a serious respiratory illness that hits infants hard has resulted in a 75 per cent reduction in babies hospitalised with the virus.

9Honey on MSN2d

RSV, influenza and the dreaded daycare sickness: Dr Golly on keeping your family healthy this winter

If the cold snap didn't tell you, the onslaught of sickness will have done it: winter is officially here. This winter, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results